Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 5/20 | 1.00 |
| ▸ | ALPL | P05186 | 3/20 | 0.60 |
| ▸ | MAOB | P27338 | 6/20 | 0.58 |
| ▸ | MAOA | P21397 | 5/20 | 0.58 |
| ▸ | ALPI | P09923 | 2/20 | 0.57 |
| ▸ | ESR1 | P03372 | 3/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.56 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.56 |
| ▸ | PDE2A | O00408 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29206959 | 0.84 | HSD17B3 (0.73) | HSD17B3ALPLMAOBMAOAALPI | |
| SCHEMBL31366988 | 0.82 | HSD17B3 (1.00) | HSD17B3MAOBESR1ESR2ERAP1 | |
| SCHEMBL591899 | 0.82 | HSD17B3 (1.00) | HSD17B3MAOBESR1ESR2ERAP1 | |
| SCHEMBL29206927 | 0.82 | HSD17B3 (0.69) | HSD17B3ALPLMAOBMAOAALPI | |
| SCHEMBL29226081 | 0.82 | HSD17B3 (0.69) | HSD17B3ALPLMAOBMAOAALPI | |
| SCHEMBL29226062 | 0.82 | HSD17B3 (0.69) | HSD17B3ALPLMAOBMAOAALPI | |
| SCHEMBL28446883 | 0.80 | HSD17B3 (0.96) | HSD17B3MAOBESR1ESR2ERAP1 | |
| SCHEMBL15842341 | 0.79 | ALPL (0.74) | HSD17B3ALPLMAOBMAOAALPI | |
| SCHEMBL11874784 | 0.79 | HSD17B3 (0.65) | HSD17B3MAOBMAOA | |
| SCHEMBL3306142 | 0.78 | HSD17B3 (0.64) | HSD17B3MAOAESR1ESR2ERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010154-A | Method for preparing high-whiteness cubic nano calcium carbonate at low temperature | 湖北三峡实验室 | 2026-05-12 | — | — | CN | claimed |
| US-20100038632-A1 | ELECTROLUMINESCENT DEVICE | OLED-T LIMITED (GB) | 2010-02-18 | — | — | US | claimed |
| US-20040092738-A1 | Silent mark for oil product and detection method thereto | SK ENERGY CO., LTD. (KR) | 2004-05-13 | — | — | US | claimed |
| EP-1309572-A4 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK CORP (KR) | 2004-03-17 | — | — | EP | claimed |
| EP-1309572-A1 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK Corporation (KR) | 2003-05-14 | — | — | EP | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2002004431-A1 | SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO | SK CORPORATION (KR) | 2002-01-17 | — | — | WO | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| CN-122010154-A | Method for preparing high-whiteness cubic nano calcium carbonate at low temperature | 湖北三峡实验室 | 2026-05-12 | — | — | CN | disclosed |
| US-20230313261-A1 | Biological Indicator Comprising Genetically-Modified Test Microorganism | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-10-05 | — | — | US | disclosed |
| US-20230193347-A1 | Biological Indicator with Test Microorganisms Enveloped by Wax Composition | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-06-22 | — | — | US | disclosed |
| CN-116194158-A | Biological indicator comprising genetically modified test microorganism | 3M创新有限公司 | 2023-05-30 | — | — | CN | disclosed |
| US-20230110772-A1 | Immobilized pH Indicator for Biological Indicator Growth Indication | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2023-04-13 | — | — | US | disclosed |
| EP-0937149-A2 | GLUCURONIDE REPRESSORS AND USES THEREOF | Cambia Biosystems LLC (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5879906-A | GENE AND PROTEIN SEQUENCES OF GLUCURONIDE REPRESSORS AND USE OF THE REPRESSOR FOR CONTROLLING GENE EXPRESSION AND DETECTING GLUCURONIDES, WHILE PROVIDING OTHER RELATED ADVANTAGES. | CAMBIA BIOSYSTEMS LLC (US) | 1999-03-09 | — | — | US | disclosed |
| WO-1997049813-A2 | GLUCURONIDE REPRESSORS AND USES THEREOF | CAMBIA BIOSYSTEMS LLC (US) | 1997-12-31 | — | — | WO | disclosed |
| EP-0171645-B1 | 2H-1-BENZOPYRAN-2-ON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS | Roche Diagnostics GmbH (DE) | 1988-11-30 | — | — | EP | disclosed |
| US-4670439-A | INHIBITING ALLERGIC REACTIONS | BOEHRINGER MANNHEIM GMBH (DE) | 1987-06-02 | — | — | US | disclosed |
| EP-0171645-A1 | 2H-1-benzopyran-2-on derivatives, process for their preparation and medicines containing these compounds | Roche Diagnostics GmbH (DE) | 1986-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092738-A1 | Silent mark for oil product and detection method thereto | NOTUM, SQLE, MSMO1 | HSD17B3 114/4885ALPL 182/4885MAOB 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.